Extracellular Matrix Lumican Promotes Bacterial Phagocytosis, and Lum-/- Mice Show Increased Pseudomonas Aeruginosa Lung Infection Severity
Overview
Authors
Affiliations
Phagocytosis is central to bacterial clearance, but the exact mechanism is incompletely understood. Here, we show a novel and critical role for lumican, the connective tissue extracellular matrix small leucine-rich repeat proteoglycan, in CD14-mediated bacterial phagocytosis. In Psuedomonas aeruginosa lung infections, lumican-deficient (Lum(-/-)) mice failed to clear the bacterium from lungs, tissues, and showed a dramatic increase in mortality. In vitro, phagocytosis of nonopsonized gram-negative Escherichia coli and P. aeruginosa was inhibited in Lum(-/-) peritoneal macrophages (MΦs). Lumican co-localized with CD14, CD18, and bacteria on Lum(+/+) MΦ surfaces. Using two different P. aeruginosa strains that require host CD14 (808) or CD18/CR3 (P1) for phagocytosis, we showed that lumican has a larger role in CD14-mediated phagocytosis. Recombinant lumican (rLum) restored phagocytosis in Lum(-/-) MΦs. Surface plasmon resonance showed specific binding of rLum to CD14 (K(A) = 2.15 × 10(6) M(-1)), whereas rLumY20A, and not rLumY21A, where a tyrosine in each was replaced with an alanine, showed 60-fold decreased binding. The rLumY20A variant also failed to restore phagocytosis in Lum(-/-) MΦs, indicating Tyr-20 to be functionally important. Thus, in addition to a structural role in connective tissues, lumican has a major protective role in gram-negative bacterial infections, a novel function for small leucine-rich repeat proteoglycans.
Biomimetic strategies for the deputization of proteoglycan functions.
Rehan I, Elnagar A, Zigo F, Sayed-Ahmed A, Yamada S Front Cell Dev Biol. 2024; 12:1391769.
PMID: 39170918 PMC: 11337302. DOI: 10.3389/fcell.2024.1391769.
Maiti G, Ashworth S, Choi T, Chakravarti S Matrix Biol. 2023; 123:48-58.
PMID: 37793508 PMC: 10841460. DOI: 10.1016/j.matbio.2023.10.001.
Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19.
Hastak P, Andersen C, Kelleher A, Sasson S Front Immunol. 2022; 13:983550.
PMID: 36211412 PMC: 9539803. DOI: 10.3389/fimmu.2022.983550.
Maiti G, Frikeche J, Lam C, Biswas A, Shinde V, Samanovic M Proc Natl Acad Sci U S A. 2021; 118(27).
PMID: 34215697 PMC: 8271568. DOI: 10.1073/pnas.2100999118.
Cicuendez M, Casarrubios L, Feito M, Madarieta I, Garcia-Urkia N, Murua O Int J Mol Sci. 2021; 22(8).
PMID: 33917732 PMC: 8068109. DOI: 10.3390/ijms22083847.